Cancer Institute A national cancer institute
designated cancer center
Profile http://med.stanford.edu/profiles/Marlene_Rabinovitch/ Email this profile Generate Profile PDF
Portrait View Larger

Marlene Rabinovitch

Academic Appointments

Key Documents

Contact Information

  • Clinical Offices
    Stanford University School of Medicine 269 Campus Drive CCSR, Room 1215A, MC: 5162 Stanford, CA 94305
    Tel Work (650) 723-8239 Fax (650) 723-6700
  • Academic Offices
    Personal Information
    Email
    Alternate Contact
    Administrative Associate Tel Work 723-8239
    Not for medical emergencies or patient use

Professional Overview

Clinical Focus

  • Cardiology (Heart), Pediatric
  • Pediatric Cardiology

Administrative Appointments

  • Director of Research, Vera Moulton Wall Center for Pulmonary Vascular Disease (2003 - present)

Honors and Awards

  • Louis and Artur Lucian Award for Research in Circulatory Diseases, McGill University (2010)
  • Scientific Accomplishment Award, American Thoracic Society (2008)
  • Distinguished Scientist Award, American Heart Association (2006)
  • Dickinson Richards Lecture, American Heart Association (2005)
  • Basic Research Prize, American Heart Association (2004)
  • Leadership Award and Prize, CIHR-Institute of Circulatory & Respiratory Health (2004)
View All 15honors and awards of Marlene Rabinovitch

Professional Education

Residency: University of Colorado Health Science Center CO (1973)
Board Certification: Pediatric Cardiology, American Board of Pediatrics (1979)
Fellowship: Children's Hospital, Harvard Medical School MA (1977)
Board Certification: General Pediatrics, American Board of Pediatrics (1976)
Internship: University of Colorado Health Science Center CO (1972)
Medical Education: McGill University, Canada (1971)
View All 8

Scientific Focus

Current Research Interests

Our research focuses on the regulation of genes associated with cardiovascular development and disease. We identified a novel smooth muscle cell elastase that has a pivotal role in the pathobiology of pulmonary hypertension, vein graft atherosclerosis, transplant arteriopathy and rejection, coronary artery disease, restenosis, myocardial ischemia and myocarditis. Inhibition of elastase prevents or reverses the pathology in experimental animals. We are now pursuing fundamental studies which address the transcriptional regulation of elastase by AML1 and how this relates to genetic mechanisms of disease, focusing on polymorphisms in the serotonin transporter, mutations in a bone morphogenetic protein receptor, and overexpression of a calcium binding protein, Mts1. These studies use cultured cells, transgenic mice, gene arrays and gene therapy and are aimed at developing new treatments.

In our studies related to regulation of cell motility, a key feature of vascular pathology, we identified a requisite increase in production of the microtubule-associated protein LC-3, which is highly conserved across species. This protein regulates the efficiency of mRNA translation of genes, including fibronectin and apolipoprotein D. We determined that LC3, through its triple arginine motif, engages an AU rich element in the 3’ untranslated region of fibronectin mRNA, to enhance efficiency of mRNA translation. We are now addressing whether this process is critical to the regulation of a constellation of transcripts necessary for cell motility in development and disease. We are pursuing evidence that LC3 is regulated by nitric oxide, and are currently investigating how this leads to its phosphorylation and binding to mRNA. In addition, we are relating LC-3 to the migration of other cell types, including neural crest cells which regulate cardiac development, as well as neuronal cells, where it is highly expressed in development, and in diseased tissues and cancer cells. We are utilizing transgenic mice, RNAi, and transcriptional profiling by DNA microarray approaches to investigate the impact of LC3-dependent mRNA translation on cell function.

We have also cloned a novel chymase that mediates enhanced experimental hypertension through processing angiotensin II, endothelin 1, and transforming growth factor beta.

Our research program harmonizes with that of Dr. Richard Bland who investigates the regulation, expression and function of genes that coordinate pulmonary alveolar and vascular development, and how they are perturbed by prematurity and mechanical ventilation, leading to chronic lung disease.

Publications

Publication tag cloud

Publication Topics

View All 232

Stanford Medicine Resources:

Footer Links: